Aymara Sancho Araiz-rekin lankidetzan egindako argitalpenak (9)

2024

  1. Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab

    Clinical Pharmacology and Therapeutics

2023

  1. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling

    Clinical Pharmacology and Therapeutics, Vol. 114, Núm. 3, pp. 623-632

  2. Characterization of the interplay between different biological factors driving tumor growth dynamics in the absence of treatment.

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Mechanistic characterization of oscillatory patterns in unperturbed tumor growth dynamics: The interplay between cancer cells and components of tumor microenvironment

    PLoS Computational Biology, Vol. 19, Núm. 10

  4. Mechanistic modelling of immuno-modulators in oncology drug development

    Mechanistic modelling of immuno-modulators in oncology drug development

  5. Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases

    Pharmaceutics, Vol. 15, Núm. 11

2021

  1. Semi-mechanistic model for the antitumor response of a combination cocktail of immuno-modulators in non-inflamed (Cold) tumors

    Cancers, Vol. 13, Núm. 20

  2. The role of mathematical models in immuno-oncology: Challenges and future perspectives

    Pharmaceutics, Vol. 13, Núm. 7

  3. Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis

    Pharmaceutical Research, Vol. 38, Núm. 12, pp. 2047-2063